Society debates seal of approval

The American Academy of Dermatology's “Seal of Recognition” program was the subject of debate at its annual meeting last month. Supporters have said the program enhances the organization's skin cancer education efforts. Trade groups and some dermatologists, however, have argued the program presents a conflict of interest, as products displaying the seal aren't independently vetted. “This scandal is further evidence of the incestuous and unethical relationships between the dermatological community and the skin care industry,” said Sarah Longwell, communications director, Indoor Tanning Association, in a statement. 

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.